Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.0124
+0.0003 (2.48%)
Oct 15, 2025, 3:59 PM EDT
Evofem Biosciences Employees
Evofem Biosciences had 32 employees as of December 31, 2024. The number of employees decreased by 6 or -15.79% compared to the previous year.
Employees
32
Change (1Y)
-6
Growth (1Y)
-15.79%
Revenue / Employee
$539,688
Profits / Employee
-$195,156
Market Cap
1.50M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 32 | -6 | -15.79% |
Dec 31, 2023 | 38 | 1 | 2.70% |
Dec 31, 2022 | 37 | -82 | -68.91% |
Dec 31, 2021 | 119 | -28 | -19.05% |
Dec 31, 2020 | 147 | 94 | 177.36% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Elite Pharmaceuticals | 68 |
Glass House Brands | 374 |
Northwest Biotherapeutics | 25 |
CytoDyn | 13 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Jushi Holdings | 1,234 |
Nuo Therapeutics | 9 |
Evofem Biosciences News
- 14 days ago - Evofem's SOLOSEC Submitted for Marketing Approval in United Arab Emirates - PRNewsWire
- 19 days ago - Evofem Biosciences Honors World Contraception Day - PRNewsWire
- 4 weeks ago - Evofem's "Say Vagina" Campaign Generates More than 2.5 Million Views Across Social Media Platforms - PRNewsWire
- 5 weeks ago - Evofem Anticipates Approval of Merger with Aditxt at Upcoming Stockholder Meeting - PRNewsWire
- 7 weeks ago - Illinois Pharmacists Can Prescribe PHEXXI Starting January 2026 Under Newly-passed Law - PRNewsWire
- 2 months ago - FDA Orange Book Lists New U.S. Patent for SOLOSEC, Evofem Biosciences' "One and Done" Oral Treatment for Bacterial Vaginosis and Trichomoniasis - PRNewsWire
- 2 months ago - Evofem Biosciences GAAP EPS of -$0.02, revenue of $4.8M - Seeking Alpha
- 2 months ago - Evofem Reports Positive Financial Results for Second Quarter of 2025, Provides Business Update - PRNewsWire